Quintiles, Sinclair ink 10-year partnership to commercialize portfolio in Mexico

Wednesday, September 19, 2012 11:37 AM

Quintiles, a fully integrated biopharmaceutical services company, and Sinclair IS Pharma, a topicals and supportive care specialist, have signed a 10-year collaboration and licensing agreement for Quintiles (Rowfarma Mexico) to commercialize Sinclair’s portfolio of dermo-cosmetic products and medical devices in Mexico.

Quintiles will handle the entire process including regulatory submissions; product importation, warehousing and distribution to wholesalers; sales force promotion to dermatologists and plastic surgeons; and marketing, advertising and promotion.

“This collaboration, a further step in Latin America, supports our company’s growth strategy: to move our product portfolio into fast-growing, emerging markets through strategic, regional partnerships,” said Chris Spooner, CEO of Sinclair IS Pharma. “Quintiles’ extensive commercialization experience and proven track record in Mexico and other emerging markets made it the clear choice to help us execute our strategy.”

The Sinclair portfolio includes: Atopiclair, for the treatment of mild to moderate atopic dermatitis; Kelo-cote silicone-gel scar reduction range, for the prevention and management of abnormal scars; Sebclair, for the treatment of seborrhoeic dermatitis; Bio-Taches, for hyperpigmentation disorders; XClair, for the treatment of radiation dermatitis; and Papulex, for the management and maintenance of mild to moderate acne.

“Our customers are thinking carefully about their strategy in emerging markets, and are looking for a trusted partner who can help navigate the complexities these markets present,” said James Featherstone, senior vice president of commercial strategy, Quintiles. “With this agreement, Quintiles will work on a wide range of services—from registration through to launch, to help Sinclair expand its geographic footprint in a more predictable manner.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 29

WCG sees ePharmaSolutions’ clinical trial portal as the next step in the data evolution, company mission

Cutting-edge advertising can ‘break through the clutter’ for successful patient recruitment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs